The stock market is unlikely to witness too many earnings downgrades from hereon as it is going into the second quarter earnings with muted expectations, says Manish Gunwani, senior fund manager with ICICI Prudential Asset Management Company.
Dilip Bhat of Prabhudas Lilladher expects pharma stocks to see a mild time-wise correction.
Technical analyst Sudarshan Sukhani of s2analytics.com said, yesterday‘s narrow range day and SGX Nifty, both tell us there will be a breakout on the upside.
Futures and Options expert, Hemant Thukral, national head-derivative desk, Aditya Birla Money says the real test for bulls will start from 6,000 to 6,050.
Rahul Mohindar, Viratechindia.com is bullish on midcap banks.
In an interview to CNBC-TV18 Ambareesh Baliga of Karvy Stock Broking said that the markets may possibly fall closer to 5,200. “Before that we could have a few small bounce backs but 5,700 levels would be a major resistance. Crossing that would be difficult,” he explained.